SCHEMBL22006507

SCHEMBL22006507

CNc1nnc(NC2CCN(O)C2)s1

nearest known ligand 0.51

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 20/20 0.51
▸ SLC6A2 P23975 1/20 0.35
▸ TACR1 P25103 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18946127 1.00 GLS (0.51) GLSSLC6A2TACR1OPRM1HTR2B
SCHEMBL17309262 0.81 GLS (0.47) GLS
SCHEMBL20373254 0.81 GLS (0.47) GLS
SCHEMBL17654164 0.68 GLS (1.00) GLS
SCHEMBL17654160 0.68 GLS (1.00) GLS
SCHEMBL17654158 0.68 GLS (1.00) GLS
SCHEMBL11584394 0.66 — —
SCHEMBL24831877 0.63 NPC1 (0.40) GLSSLC6A2TACR1OPRM1HTR2B
SCHEMBL17664538 0.61 GLS (0.61) GLS
SCHEMBL13599897 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3383872-B1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER CANCER RESEARCH TECH LTD (GB) 2020-05-20 — — EP disclosed
Send feedback